SecBot SecBot
SECBOTREPLAY Home › Report › VALN

VALN · Valneva announced its participation in the 26th World Vaccine Congress…

Valneva SE · 6-K filed Mar 26, 2026 at 12:55 ET

At the news

NEUTRALIMPACT 3/10

6-K filed Mar 26, 2026 at 12:55 ET

Valneva announced its participation in the 26th World Vaccine Congress in Washington, DC, where it will present updates on its chikungunya vaccine IXCHIQ, including real-world evidence from a pilot vaccination campaign in Brazil involving over 12,000 individuals. The company will also engage in discussions on mosquito-borne diseases and meet with current and potential partners.

  • Valneva will present chikungunya vaccine IXCHIQ Phase IV and real-world evidence data at the World Vaccine Congress on April 1, 2026.
  • Over 12,000 people have been vaccinated in a pilot campaign in Brazil with IXCHIQ, conducted in partnership with Instituto Butantan.
  • The data presented will support post-marketing commitments and evaluate the real-world effectiveness and safety of IXCHIQ.
  • Valneva executives will participate in a panel discussion on mosquito-borne vaccines and outbreak response.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access